Plavix Makers Fight For Exclusivity

Law360, New York (January 22, 2007, 12:00 AM EST) -- Sanofi-Aventis and Bristol-Myers Squibb Co. begged the court to uphold their patent for blood thinning medication Plavix, as a trial over the blockbuster drug got underway Monday.

The trial pits the brand name drug titans against Canada-based generic maker Apotex Inc., which launched an “at-risk” generic version of Plavix on Aug. 8 following the failure of a settlement deal with France-based Sanofi and its U.S. partner Bristol-Myers.

The settlement would have delayed a generic version of the drug from hitting the market until 2011.

In opening...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.